TY - JOUR
T1 - Shotgun metagenomics reveals alteration of gut microbiota and metabolic pathways in adults with poor sleep quality
AU - Kim, Sun Young
AU - Woo, So Youn
AU - Kim, Hae Ri
AU - Kim, Na Young
AU - Kim, Hyung Lae
AU - Chang, Yoosoo
AU - Ryu, Seungho
AU - Kim, Han Na
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/10
Y1 - 2025/10
N2 - Introduction: Emerging evidence suggests that the gut microbiome plays a role in sleep disturbance. This study explored the characteristics of the gut microbiome and the functional metabolic pathways related to sleep quality. Methods: A total of 588 participants were recruited. Sleep quality was assessed using the Pittsburgh Sleep Quality Index, employing a cutoff score of 8.5. Based on this criterion, 42 individuals with poor sleep quality (PSQ) and 546 healthy controls with good sleep quality (GSQ) were identified. The fecal microbiome was analyzed using shotgun whole-metagenome sequencing, and groups were compared based on diversity metrics, differentially abundant species, metabolic pathways and metabolites. Results: No significant differences in alpha and beta diversity indices were observed between individuals experiencing subjective sleep disturbances and those who did not. Klebsiella pneumoniae was more abundant in the PSQ group (β = 0.476; q = 0.017). Additionally, the following metabolic pathways were enriched in the PSQ group: octane oxidation (coefficient = 0.495, q = 0.033), the superpathway of acetyl-CoA biosynthesis (coefficient = 0.377, q = 0.025), superpathway of (Kdo)2-lipid A biosynthesis (coefficient = 0.367, q = 0.026), petroselinate biosynthesis (coefficient = 0.353, q = 0.034), and superpathway of histidine, purine, and pyrimidine biosynthesis (coefficient = 0.349, q = 0.042). When metabolites levels associated with poor sleep quality were inferred using MelonnPan, higher xanthine levels were observed in the PSQ group (coefficient = 0.018; q = 0.025). Conclusion: In summary, this study poses significant questions regarding the relationship between the gut microbiome and poor sleep quality.
AB - Introduction: Emerging evidence suggests that the gut microbiome plays a role in sleep disturbance. This study explored the characteristics of the gut microbiome and the functional metabolic pathways related to sleep quality. Methods: A total of 588 participants were recruited. Sleep quality was assessed using the Pittsburgh Sleep Quality Index, employing a cutoff score of 8.5. Based on this criterion, 42 individuals with poor sleep quality (PSQ) and 546 healthy controls with good sleep quality (GSQ) were identified. The fecal microbiome was analyzed using shotgun whole-metagenome sequencing, and groups were compared based on diversity metrics, differentially abundant species, metabolic pathways and metabolites. Results: No significant differences in alpha and beta diversity indices were observed between individuals experiencing subjective sleep disturbances and those who did not. Klebsiella pneumoniae was more abundant in the PSQ group (β = 0.476; q = 0.017). Additionally, the following metabolic pathways were enriched in the PSQ group: octane oxidation (coefficient = 0.495, q = 0.033), the superpathway of acetyl-CoA biosynthesis (coefficient = 0.377, q = 0.025), superpathway of (Kdo)2-lipid A biosynthesis (coefficient = 0.367, q = 0.026), petroselinate biosynthesis (coefficient = 0.353, q = 0.034), and superpathway of histidine, purine, and pyrimidine biosynthesis (coefficient = 0.349, q = 0.042). When metabolites levels associated with poor sleep quality were inferred using MelonnPan, higher xanthine levels were observed in the PSQ group (coefficient = 0.018; q = 0.025). Conclusion: In summary, this study poses significant questions regarding the relationship between the gut microbiome and poor sleep quality.
KW - Gut microbiota
KW - Gut-brain axis
KW - Poor sleep quality
KW - Shotgun metagenomics
UR - https://www.scopus.com/pages/publications/105012507103
U2 - 10.1016/j.psyneuen.2025.107565
DO - 10.1016/j.psyneuen.2025.107565
M3 - Article
C2 - 40773868
AN - SCOPUS:105012507103
SN - 0306-4530
VL - 180
JO - Psychoneuroendocrinology
JF - Psychoneuroendocrinology
M1 - 107565
ER -